BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34528528)

  • 21. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
    Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
    Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of tumor-associated antigens with diagnostic ability of colorectal cancer by in-depth immunomic and seroproteomic analysis.
    Garranzo-Asensio M; San Segundo-Acosta P; Povés C; Fernández-Aceñero MJ; Martínez-Useros J; Montero-Calle A; Solís-Fernández G; Sanchez-Martinez M; Rodríguez N; Cerón MÁ; Fernandez-Diez S; Domínguez G; de Los Ríos V; Peláez-García A; Guzmán-Aránguez A; Barderas R
    J Proteomics; 2020 Mar; 214():103635. PubMed ID: 31918032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.
    Luo B; Yun X; Fan R; Lin YD; He SJ; Zhang QM; Mo FR; Chen F; Xiao SW; Xie XX
    Int J Clin Exp Pathol; 2013; 6(12):2835-45. PubMed ID: 24294369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endosialin (TEM1) as a Diagnostic, Progression, and Prognostic Serum Marker for Patients With Colorectal Cancer-A Preliminary Study.
    Pietrzyk Ł; Wdowiak P
    Cancer Control; 2020; 27(1):1073274820903351. PubMed ID: 32107922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients.
    Álvarez-Fernández SM; Barbariga M; Cannizzaro L; Cannistraci CV; Hurley L; Zanardi A; Conti A; Sanvito F; Innocenzi A; Pecorelli N; Braga M; Alessio M
    Oncotarget; 2016 Nov; 7(48):80059-80076. PubMed ID: 27517630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up.
    Suppiah A; Alabi A; Madden L; Hartley JE; Monson JR; Greenman J
    Int J Colorectal Dis; 2008 Jun; 23(6):595-600. PubMed ID: 18330580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction.
    Nassar FJ; Msheik ZS; Nasr RR; Temraz SN
    Clin Epigenetics; 2021 May; 13(1):111. PubMed ID: 34001239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum p53 antibody assay: evaluation in colorectal cancer].
    Hammel P; Soussi T
    Rev Med Interne; 2000 Feb; 21(2):167-73. PubMed ID: 10703073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-derived molecular signatures as biomarker panels for the early detection of colorectal cancer.
    Gan X; Wang T; Chen ZY; Zhang KH
    Mol Biol Rep; 2020 Oct; 47(10):8159-8168. PubMed ID: 32979165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.
    Sun F; Tan YA; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Ying HQ; Wang XZ
    J Clin Lab Anal; 2019 Jan; 33(1):e22635. PubMed ID: 30047185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsa_circ_001659 serves as a novel diagnostic and prognostic biomarker for colorectal cancer.
    He B; Chao W; Huang Z; Zeng J; Yang J; Luo D; Huang S; Pan H; Hao Y
    Biochem Biophys Res Commun; 2021 Apr; 551():100-106. PubMed ID: 33725570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal Cancer.
    Teras LR; Gapstur SM; Maliniak ML; Jacobs EJ; Gansler T; Michel A; Pawlita M; Waterboer T; Campbell PT
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):219-223. PubMed ID: 29254936
    [No Abstract]   [Full Text] [Related]  

  • 33. Seroreactivity Against Tyrosine Phosphatase PTPRN Links Type 2 Diabetes and Colorectal Cancer and Identifies a Potential Diagnostic and Therapeutic Target.
    Garranzo-Asensio M; Solís-Fernández G; Montero-Calle A; García-Martínez JM; Fiuza MC; Pallares P; Palacios-Garcia N; García-Jiménez C; Guzman-Aranguez A; Barderas R
    Diabetes; 2022 Mar; 71(3):497-510. PubMed ID: 35040477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer.
    Chen JS; Chen KT; Fan WC; Yu JS; Chang YS; Chan EC
    Clin Chem Lab Med; 2010 May; 48(5):719-25. PubMed ID: 20178447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SALL4 as a new biomarker for early colorectal cancers.
    Ardalan Khales S; Abbaszadegan MR; Abdollahi A; Raeisossadati R; Tousi MF; Forghanifard MM
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):229-35. PubMed ID: 25156818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple serological biomarkers for colorectal cancer detection.
    Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC
    Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.
    Luo H; Zhao Q; Wei W; Zheng L; Yi S; Li G; Wang W; Sheng H; Pu H; Mo H; Zuo Z; Liu Z; Li C; Xie C; Zeng Z; Li W; Hao X; Liu Y; Cao S; Liu W; Gibson S; Zhang K; Xu G; Xu RH
    Sci Transl Med; 2020 Jan; 12(524):. PubMed ID: 31894106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study.
    Wei SC; Tsao PN; Wang YT; Lin BR; Wu DC; Tsai WS; Chen JS; Wong JM
    Cancer Med; 2019 Jul; 8(7):3583-3591. PubMed ID: 31063258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.
    Li L; Xing S; Wu M; Ao Y; Zheng X; Cai R; Han R; Li J; Li X; Zeng Q
    Cancer Control; 2021; 28():10732748211048292. PubMed ID: 34615391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
    Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.